# The Effects of BAK on the Blood Aqueous Barrier of Pseudophakic Patients

> **NCT01280110** · PHASE4 · COMPLETED · sponsor: **University of Campinas, Brazil** · enrollment: 44 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** Hydroxypropylmethylcellulose
- **DRUG:** Carboxymethylcellulose

## Key facts

- **NCT ID:** NCT01280110
- **Lead sponsor:** University of Campinas, Brazil
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-12
- **Final completion:** 2012-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2012-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01280110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01280110, "The Effects of BAK on the Blood Aqueous Barrier of Pseudophakic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01280110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*